Abstract
This is a 16-subject trial to demonstrate the safety of allogeneic hMSCs administered via infusion therapy for diabetic subjects with endothelial dysfunction.
University of Miami Miller School of Medicine, Miami, Florida, USA
ClinicalTrials.gov Identifier: NCT02886884
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Weiss, J.N. (2022). Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial Dysfunction in Diabetic Subjects (ACESO). In: Stem Cell Surgery Trials in Heart Failure and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-030-78010-4_29
Download citation
DOI: https://doi.org/10.1007/978-3-030-78010-4_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-78009-8
Online ISBN: 978-3-030-78010-4
eBook Packages: MedicineMedicine (R0)